Adalmario Couto

Adalmario Couto, CFA, has extensive experience in finance and investment, currently serving as a Board Member at Bionovis since April 2021 and holding multiple roles at Hypera Pharma, including Investor Relations Officer, Innovation & Business Development, and Chief Financial Officer since September 2016. Previously, Adalmario Couto worked at MC Capital Group Ltd as a Portfolio Manager & Analyst focused on alternative asset management for a decade, co-managing a Global Macro Hedge Fund. Prior positions include Investment Banking Associate at Brasilpar, Project Finance Analyst at Banco Schahin, and Sales Trader & Desk Analyst at HSBC Investments. Adalmario Couto holds a Bachelor of Science in Business Administration from FGV - Fundação Getulio Vargas.